Redwood Shores, CA (PRWEB) September 27, 2012
Model N, the leader in Revenue Management solutions, is reporting a record 26 Model N Suite go-lives over the last year. The go-lives are spread across both the Life Sciences and High Tech industries and include several Model N Cloud deployments.
“In this stubbornly unpredictable economy, extracting higher revenue and margins out of existing business has become imperative for Life Sciences and High Tech manufacturers,” said Lawrence Whittle, Chief Sales and Marketing Officer at Model N. “The number of Model N go-lives this fiscal year reflects the strong business case for fully integrated Revenue Management among industry leaders as well as the rapid time to value provided by Model N.”
Model N Cloud Fueling Revenue Management Adoption
The Model N Cloud is designed to handle the large transactional volumes, complex computational requirements, and heavy data storage capacity needed by large organizations to manage their revenue life cycles across multiple product lines, divisions, and countries.
Delivering enterprise solutions via the cloud increases flexibility, reduces capital expenses, and simplifies deployment, resulting in improved return on assets, accelerated time to value, and easier scalability. Global business gain visibility while also more easily supporting localization requirements such as language, currency, country-specific data formats, and unique regional business processes.
About Model N
Model N, the leader in Revenue Management solutions, drives improved pricing, margin, and revenue performance through a powerful combination of best practices, highly configurable software applications, comprehensive services, and actionable analytics across the complete functional spectrum of pricing, contracting, rebating, sales, and marketing. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and High Tech manufacturers across more than 50 countries. Global Customers include: Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Hospira, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and Watson Pharmaceuticals. Whether you are an emerging business or a global leader, Model N results in revenue. http://www.modeln.com
Model N is a registered trademark of Model N, Inc. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.